Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nitazoxanide with PEG/RBV for HIV/HCV Coinfection
NCT00991289Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Jan 2010
- Primary completion
- Nov 2010
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of nitazoxanide in hepatitis C (HCV), sponsored by National Institute of Allergy and Infectious Diseases. Started Jan 2010; status: completed.
02
Drugs
nitazoxanide
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT00991289.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00991289.